Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
07/2008
07/17/2008WO2008056257A3 Novel triazinedione derivatives as gaba-b receptor modulators
07/17/2008WO2008045564A8 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor
07/17/2008WO2008042282B1 Imidazole-4, 5-dicarboxamide derivatives as jak-2 modulators
07/17/2008WO2008020405A3 Azetidine compounds as orexin receptor antagonists
07/17/2008US20080171888 Process for making spirolactone compounds
07/17/2008US20080171882 [(4S)-4-Methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride and [(4R)-4-methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride; chemical intermediates for enzyme inhibitors
07/17/2008US20080171778 N3 alkylated benzimidazole derivatives as mek inhibitors
07/17/2008US20080171758 Compounds and methods for the treatment of cancer
07/17/2008US20080171755 4-(4-Benzo[1,3]dioxol-5-yl-1H-pyrazol-3-yl)-2-methylpyrimidine; affinity for activin receptor-like kinases 4/5; potent antagonists of these Transforming Growth Factor beta family type receptors; fibrosis; anticarcinogenic and -metastasis agents; demelination; expression inhibited by reducing signal path
07/17/2008US20080171733 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine
07/17/2008US20080170993 Thymidine analogs for imaging
07/17/2008DE19618586B4 Monoazo-Dispersionsfarbstoffe Monoazo disperse dyes
07/17/2008CA2674408A1 Radiolabelling via fluorination of aziridines
07/17/2008CA2673377A1 Heteroaryl-substituted serineamides
07/16/2008EP1944305A1 Quinoline derivatives as phosphodiesterase inhibitors
07/16/2008EP1944300A2 Prodrugs of aspartyl protease inhibitors
07/16/2008EP1944292A1 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
07/16/2008EP1944288A1 Radiolabelling via fluorination of aziridines
07/16/2008EP1944024A1 O-substituted aniline derivative and antioxidant drug
07/16/2008EP1943235A1 Arylurea derivatives as modulators of chemokine receptor activity
07/16/2008EP1943230A2 Compounds which have activity at m1 receptor and their uses in medicine
07/16/2008EP1943222A1 Antibacterial active 5-chinolin derivative
07/16/2008EP1943220A2 Novel indole-containing beta agonists, method for producing them and their use as drugs
07/16/2008EP1942893A2 Piperidine glycine transporter inhibitors
07/16/2008EP1942890A2 Chemokine receptor binding compounds
07/16/2008EP1556376B1 Large conductance calcium-activated k channel opener
07/16/2008EP1527049B1 Fused heterocyclic compounds as peptidase inhibitors
07/16/2008EP1476151B1 1-arylsulfonyl-3-substitued indole and indoline derivates useful in the treatment of central nervous system disorders
07/16/2008EP1392655B1 Potassium channel openers
07/16/2008EP1386913B1 Pyrrole derivative
07/16/2008EP1286966B1 4-aminopiperidine derivatives and their use as medicine
07/16/2008EP1165551B1 C10 carbamoyloxy substituted taxanes as antitumor agents
07/16/2008EP1054004B1 Novel pyrimidine-5-carboxamide derivatives
07/16/2008CN101223164A Substituted piperidines as renin inhibitors
07/16/2008CN101223163A New 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
07/16/2008CN101223155A Benzoheterocyclylethylcarboxamide derivatives
07/16/2008CN101223147A Pyrimidindione derivatives as prokineticin 2 receptor antagonists
07/16/2008CN101223146A Modulators of ATP-binding cassette transporters
07/16/2008CN101222924A Substituted piperidine derivatives as somatostatin sst1 receptor antagonists
07/16/2008CN101220022A 2-(5-chlorophenyl-2-tetrol formamido)ethanamide pyrimidine derivant, derivant, preparation and application thereof
07/16/2008CN101220021A 4-substituted phenoxyl quinoline compounds and midbody, production method, application thereof
07/16/2008CN100402545C Methods and compositions for treating hepatitis c virus
07/16/2008CN100402525C Pyridine derivatives as fungicidal compounds
07/16/2008CN100402524C Synthesis of 8-(4,6-dimethoxy pyrimidine oxy)-2-substituted phentriazine-1-one derivative and its herbicide activity
07/16/2008CN100402521C 4-imidazolin-2-one compounds
07/16/2008CN100402501C Aminoquinoline derivatives and their use as adenosine A3 ligands
07/16/2008CN100402499C 2-iminopyrrolidine derivatives
07/15/2008US7399866 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents
07/15/2008US7399865 such as (E)-N-{4-[4-(benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide used as antineoplastic agents, or inhibitors of the HER-2 gene or proteins and epidermal growth factor receptor enzymes
07/15/2008US7399780 pyridin-2-yl-1H-indole or pyrimidin-4-yl-1H-indole derivatives; enzyme inhibitor of glycogen synthase kinase-3; treating dementia, Alzheimer's Disease, Parkinson's Disease, amyotrophic lateral sclerosis, corticobasal degeneration, Down syndrome, Huntington's Disease
07/15/2008US7399779 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonists
07/15/2008US7399775 β-amyloid protein production/secretion inhibitor
07/15/2008US7399774 6-substituted nicotinamide derivatives as opioid receptor antagonists
07/15/2008US7399773 Intermediates in the synthesis of atorvastatin calcium (Lipitor (reg)), 5-(4-fluorophenyl)-2-isopropyl-1-(4-(morpholinocarbonylmethylcarbonyl)-2-hydroxybutyl)-4-phenyl-3-(N-phenylcarbamoyl)-1H-pyrrole for example
07/15/2008US7399771 Piperidine derivatives as CCR5 inhibitors
07/15/2008US7399767 Heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors
07/15/2008US7399765 Substituted diazabicycloalkane derivatives
07/15/2008US7399761 Phthalazine derivatives with angiogenesis inhibiting activity
07/15/2008US7399639 Sensors, and methods of making and using the same
07/15/2008CA2480583C Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
07/15/2008CA2421120C Quinolinone derivatives as tyrosine kinase inhibitors
07/15/2008CA2279620C 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4)
07/10/2008WO2008083354A1 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors
07/10/2008WO2008083124A1 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
07/10/2008WO2008082487A2 Novel jnk inhibitors
07/10/2008WO2008080969A1 Carboxamide compounds and their use as calpain inhibitors
07/10/2008WO2008080965A2 Hiv inhibiting 5,6-substituted pyrimidines
07/10/2008WO2008080964A1 Hiv inhibiting 6-substituted pyrimidines
07/10/2008WO2008060799A3 Synthesis of selected stereoisomers of certain substituted alcohols
07/10/2008WO2008048991A3 Organic compounds
07/10/2008US20080167367 Stable hydrate of a muscarinic receptor antagonist
07/10/2008US20080167353 To treat viral infections and tumors; hepadnaviruses, flaviviruses, herpesviruses and human immunodeficiency virus; treating 3TC (L(-)SddC) resistant hepatitis B virus infections; 9-benzo[1,3]dioxol-5-yl-8-benzyloxymethyl-naphtho[1,2-d][1,3]dioxole-7-carboxylic acid benzyl ester
07/10/2008US20080167318 Pharmaceutically active pyrrolidine derivatives
07/10/2008US20080167310 Syndrome X, antidiabetic agents; hypoglycemic agents;antilipemic agents; artherosclerosis; cardiovascular disorders
07/10/2008US20080167301 Novel Hydroxy-6-Heteroarylphenanthridines and Their Use as Pde4 Inhibitors
07/10/2008US20080167300 N-(Arylidene)morpholinylpyridinylhydrazine derivatives, e.g., N-{4-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-morpholin-4-yl-pyridin-2-yl}-N'-(3-methyl-benzylidene)-hydrazine, are used for treating interleukin-12 overproduction-related disorders including inflammatory diseases
07/10/2008US20080167288 Substituted cyclic hydroxamates as lnhibitors of matrix metalloproteinases
07/10/2008US20080167255 4-biarylyl-1-phenylazetidin-2-ones
07/10/2008US20080166362 New effector conjugates, process for their production and their pharmaceutical use
07/10/2008CA2710046A1 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors
07/10/2008CA2674237A1 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
07/10/2008CA2674185A1 Hiv inhibiting 5,6-substituted pyrimidines
07/10/2008CA2674178A1 Hiv inhibiting 6-substituted pyrimidines
07/10/2008CA2674055A1 Chemical linkers and cleavable substrates and conjugates thereof
07/10/2008CA2673580A1 Carboxamide compounds and their use as calpain inhibitors
07/10/2008CA2672940A1 Novel jnk inhibitors
07/09/2008EP1942105A1 Aminodihydrothiazine derivative
07/09/2008EP1942101A1 Secretase inhibitor
07/09/2008EP1940845A1 Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, ibs and functional dyspepsia
07/09/2008EP1940827A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
07/09/2008EP1940826A1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4
07/09/2008EP1940823A2 Substituted 1-amino-phthalzine derivatives, preparation and therapeutic use thereof
07/09/2008EP1940807A1 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
07/09/2008EP1940788A1 1-benzylindole-2-carboxamide derivatives
07/09/2008EP1940516A2 Benzopyran and pyranopyridine derivatives as potassium channel openers
07/09/2008EP1940401A2 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
07/09/2008EP1578744B1 Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists
07/09/2008EP1572648B1 3,6-disubstituted azabicyclo (3.1.0)-hexane derivatives as muscarinic receptor antagonists
07/09/2008EP1332133B1 Metabotropic glutamate receptor antagonists
07/09/2008EP1220842B1 Cyclic amine compound as ccr5 antagonist